查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1942464

2026年全球输血诊断市场报告

Blood Transfusion Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，输血诊断市场显着扩张，预计将从2025年的49.6亿美元成长到2026年的53.5亿美元，复合年增长率为7.9%。过去几年成长要素包括：先进血液学诊断设备的供不应求、对人工血型鑑定方法的依赖、医院输血数量的增加、输血传播性行为感染的日益普遍以及缺乏标准化试剂和试剂盒。

预计未来几年输血诊断市场将维持强劲成长，2030年市场规模将达到68.6亿美元，复合年增长率（CAGR）为6.4%。预测期内的成长要素包括：高通量自动化血液筛检系统的发展、核酸增幅检查和快速检测需求的成长、血库和诊断检查室投资的增加、数位化和人工智慧诊断解决方案的普及，以及血浆分馏和研究活动的拓展。预测期内的主要趋势包括：对快速准确血型鑑定的需求不断增长、自动化血液处理系统的广泛应用、疾病筛检能力的提升、血浆分馏和诊断检查室的增长，以及对标准化和品管的日益重视。

预计未来外科手术数量的不断增长将推动输血诊断市场的发展。外科手术是指运用手工或器械技术治疗损伤、疾病或病症的医疗程序。随着全球外科手术数量的持续增长，对安全且相容的输血的需求也日益增长，以补充手术过程中流失的血液。输血诊断在筛检和配对捐血、预防输血相关感染疾病和併发症、改善临床疗效以及确保病患安全方面发挥着至关重要的作用。例如，根据美国非营利组织美国整形外科医师协会 (ASPS) 预测，截至 2024 年 6 月，微创外科手术的数量预计将在 2023 年增长 7%，比外科手术的整体成长率高出 2%。手部外科手术（例如腕隧道症候群、关节炎和扳机指手术）总数为 207,887 例，比 2022 年增加 2%。因此，外科手术数量的增加正在推动输血诊断市场的成长。

血液相关疾病盛行率的不断上升预计将持续推动输血诊断市场的成长。血液相关疾病包括贫血、白血病、凝血障碍以及其他影响血液成分、功能或生成的疾病。输血诊断透过确保血液製品的相容性并降低患者风险，有助于早期发现并安全管理这些疾病。例如，根据美国癌症协会（American Cancer Society Inc.）——一家总部位于美国的专业组织——的数据显示，截至2023年1月，美国新增白血病病例约59,610例，白血病相关死亡病例约23,710例，其中急性骨髓性白血病新增病例约20,380例，占比最大。因此，血液相关疾病盛行率的不断上升正在促进输血诊断市场的扩张。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球输血诊断市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 对快速准确血型鑑定的需求日益增长
    • 扩大自动化血液处理系统的引入
    • 扩大疾病筛检能力
    • 血浆分馏和诊断检查室生长
    • 更加重视标准化和品管

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 血库
  • 血浆分馏公司
  • 研究所

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球输血诊断市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球输血诊断市场规模、比较及成长率分析
  • 全球输血诊断市场表现：规模与成长，2020-2025年
  • 全球输血诊断市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 按类型
  • 仪器及试剂盒、试剂、其他类型
  • 透过技术
  • 西方墨点法、ELISA、核酸扩增、萤光检测、快速检测
  • 透过使用
  • 血型鑑定、疾病筛检
  • 最终用户
  • 医院、诊断检查室、血库、血浆分馏公司
  • 按类型细分：设备和套件
  • 血型鑑定设备、交叉配对检查盒、血液筛检设备、自动化血液处理系统
  • 按类型细分：试剂
  • 抗血清、品管溶液、血型鑑定试剂、酵素及其他试剂
  • 按类型细分：其他
  • 软体解决方案、耗材、培训和支援服务

第十章 区域与国家分析

  • 全球输血诊断市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球输血诊断市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 血液输注诊断市场：竞争格局与市场份额，2024 年
  • 血液输注诊断市场：公司估值矩阵
  • 血液输注诊断市场：公司概况
    • Fresenius Kabi AG
    • Becton Dickinson and Company
    • Baxter International Inc.
    • Medline Industries LP
    • Grifols SA

第37章：其他领先和创新企业

  • Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen SA, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年输血诊断市场：提供新机会的国家
  • 2030年输血诊断市场：新兴细分市场机会
  • 2030年血液输注诊断市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MBTDR03_G26Q1

Blood transfusion diagnostics involve tests performed before blood transfusion, such as blood typing and disease screening, to ensure compatibility and safety between donor and recipient.

The main types of blood transfusion diagnostics include instruments and kits, reagents, and others. Blood transfusion diagnostic kits are used for blood collection and transfusion processes. The technologies employed in blood transfusion diagnostics include western blot, ELISA, nucleic acid amplification tests, fluorescence assays, and rapid tests, which are used for applications such as blood typing and disease screening. The end users include hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies.

Tariffs are impacting the blood transfusion diagnostics market by increasing costs for imported instruments, reagents, and automated systems. Segments like automated blood processing systems and high-quality reagents are most impacted, particularly in Asia-Pacific regions such as China and India, which are major manufacturing hubs. These tariffs have led to higher production costs and potential delays in adoption. On the positive side, they encourage local manufacturing, development of alternative reagents, and investment in domestic diagnostic technologies.

The blood transfusion diagnostics market research report is one of a series of new reports from The Business Research Company that provides blood transfusion diagnostics market statistics, including blood transfusion diagnostics industry global market size, regional shares, competitors with a blood transfusion diagnostics market share, detailed blood transfusion diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the blood transfusion diagnostics industry. This blood transfusion diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood transfusion diagnostics market size has grown strongly in recent years. It will grow from $4.96 billion in 2025 to $5.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to limited availability of advanced blood diagnostics instruments, reliance on manual blood grouping methods, increasing hospital blood transfusion procedures, growing prevalence of transfusion-transmissible infections, lack of standardized reagents and kits.

The blood transfusion diagnostics market size is expected to see strong growth in the next few years. It will grow to $6.86 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to development of high-throughput automated blood screening systems, increasing demand for nucleic acid amplification and rapid tests, rising investment in blood banks and diagnostic laboratories, adoption of digital and AI-enabled diagnostic solutions, expansion of plasma fractionation and research activities. Major trends in the forecast period include rising demand for rapid and accurate blood typing, increasing adoption of automated blood processing systems, expansion of disease screening capabilities, growth in plasma fractionation and diagnostic laboratories, enhanced focus on standardization and quality control.

The growing number of surgical procedures is expected to propel the growth of the blood transfusion diagnostics market going forward. Surgical procedures are medical interventions performed to treat injuries, diseases, or disorders using manual or instrumental techniques. As the global volume of surgeries continues to rise, the demand for safe and compatible blood transfusions increases to replace blood lost during surgical interventions. Blood transfusion diagnostics play a vital role in screening and matching donor blood, preventing transfusion-related infections and complications, and ensuring patient safety while improving clinical outcomes. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, exceeding the growth rate of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger procedures, totaled 207,887 cases, reflecting a 2% increase from 2022. Therefore, the rising number of surgical procedures is driving the growth of the blood transfusion diagnostics market.

The increasing prevalence of blood-related diseases is expected to drive the growth of the blood transfusion diagnostics market going forward. Blood-related diseases include disorders that affect blood composition, function, or production, such as anemia, leukemia, and clotting disorders. Blood transfusion diagnostics support early detection and safe management of these conditions by ensuring compatible blood products and reducing patient risk. For example, in January 2023, according to the American Cancer Society Inc., a US-based professional organization, approximately 59,610 new cases of leukemia and 23,710 leukemia-related deaths were reported, including about 20,380 new cases of acute myeloid leukemia. Therefore, the rising prevalence of blood-related diseases is contributing to the expansion of the blood transfusion diagnostics market.

Major companies operating in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion systems, to improve blood typing accuracy, enhance patient safety, reduce the risk of transfusion-transmitted infections, and streamline transfusion workflows. Innovations in transfusion technology encompass advancements in the methods, devices, and processes used in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a significant innovation in transfusion grouping and blood testing. Omnys is an advanced diagnostic platform designed to deliver rapid and precise blood typing, compatibility testing, and pathogen detection. This technology utilizes advanced biomarker identification and automation to optimize transfusion processes and ensure safe matching of blood products to patients.

Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.

North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the blood transfusion diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The blood transfusion diagnostics market consists of revenues earned by entities by providing installation and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood transfusion diagnostics market also includes sales of blood transfusion diagnostics devices. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Transfusion Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses blood transfusion diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for blood transfusion diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood transfusion diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Instruments And Kits; Reagents; Other Types
  • 2) By Technology: Western Blot; ELISA; Nucleic Acid Amplification; Fluorescence Assay; Rapid Test
  • 3) By Application: Blood Grouping; Disease Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Blood Banks; Plasma Fractionation Companies
  • Subsegments:
  • 1) By Instruments And Kits: Blood Typing Instruments; Cross-Matching Kits; Blood Screening Instruments; Automated Blood Processing Systems
  • 2) By Reagents: Antisera; Control Solutions; Blood Grouping Reagents; Enzymes And Other Reagents
  • 3) By Other Types: Software Solutions; Consumables; Training And Support Services
  • Companies Mentioned: Fresenius Kabi AG; Becton Dickinson and Company; Baxter International Inc.; Medline Industries LP; Grifols SA; Terumo Corporation; Haemonetics Corporation; Sarstedt AG & Co KG; Cerus Corporation; Charter Medical Ltd; Kawasumi Laboratories Inc; Macopharma SA; GenesisBPS Inc; Werfen S.A; B Braun Melsungen AG; Immucor Inc; Kaneka Corporation; Nipro Medical Corporation; Teleflex Incorporated; Smiths Medical; HLL Lifecare Limited.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Blood Transfusion Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Blood Transfusion Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Blood Transfusion Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Blood Transfusion Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Demand For Rapid And Accurate Blood Typing
    • 4.2.2 Increasing Adoption Of Automated Blood Processing Systems
    • 4.2.3 Expansion Of Disease Screening Capabilities
    • 4.2.4 Growth In Plasma Fractionation And Diagnostic Laboratories
    • 4.2.5 Enhanced Focus On Standardization And Quality Control

5. Blood Transfusion Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Blood Banks
  • 5.4 Plasma Fractionation Companies
  • 5.5 Research Institutions

6. Blood Transfusion Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Blood Transfusion Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Blood Transfusion Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Blood Transfusion Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Blood Transfusion Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Blood Transfusion Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Blood Transfusion Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Blood Transfusion Diagnostics Market Segmentation

  • 9.1. Global Blood Transfusion Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Instruments And Kits, Reagents, Other Types
  • 9.2. Global Blood Transfusion Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test
  • 9.3. Global Blood Transfusion Diagnostics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Grouping, Disease Screening
  • 9.4. Global Blood Transfusion Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
  • 9.5. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Instruments And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems
  • 9.6. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents
  • 9.7. Global Blood Transfusion Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software Solutions, Consumables, Training And Support Services

10. Blood Transfusion Diagnostics Market Regional And Country Analysis

  • 10.1. Global Blood Transfusion Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Blood Transfusion Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Blood Transfusion Diagnostics Market

  • 11.1. Asia-Pacific Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Blood Transfusion Diagnostics Market

  • 12.1. China Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Blood Transfusion Diagnostics Market

  • 13.1. India Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Blood Transfusion Diagnostics Market

  • 14.1. Japan Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Blood Transfusion Diagnostics Market

  • 15.1. Australia Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Blood Transfusion Diagnostics Market

  • 16.1. Indonesia Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Blood Transfusion Diagnostics Market

  • 17.1. South Korea Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Blood Transfusion Diagnostics Market

  • 18.1. Taiwan Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Blood Transfusion Diagnostics Market

  • 19.1. South East Asia Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Blood Transfusion Diagnostics Market

  • 20.1. Western Europe Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Blood Transfusion Diagnostics Market

  • 21.1. UK Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Blood Transfusion Diagnostics Market

  • 22.1. Germany Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Blood Transfusion Diagnostics Market

  • 23.1. France Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Blood Transfusion Diagnostics Market

  • 24.1. Italy Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Blood Transfusion Diagnostics Market

  • 25.1. Spain Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Blood Transfusion Diagnostics Market

  • 26.1. Eastern Europe Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Blood Transfusion Diagnostics Market

  • 27.1. Russia Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Blood Transfusion Diagnostics Market

  • 28.1. North America Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Blood Transfusion Diagnostics Market

  • 29.1. USA Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Blood Transfusion Diagnostics Market

  • 30.1. Canada Blood Transfusion Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Blood Transfusion Diagnostics Market

  • 31.1. South America Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Blood Transfusion Diagnostics Market

  • 32.1. Brazil Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Blood Transfusion Diagnostics Market

  • 33.1. Middle East Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Blood Transfusion Diagnostics Market

  • 34.1. Africa Blood Transfusion Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Blood Transfusion Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Blood Transfusion Diagnostics Market Regulatory and Investment Landscape

36. Blood Transfusion Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Blood Transfusion Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Blood Transfusion Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Blood Transfusion Diagnostics Market Company Profiles
    • 36.3.1. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Grifols SA Overview, Products and Services, Strategy and Financial Analysis

37. Blood Transfusion Diagnostics Market Other Major And Innovative Companies

  • Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical

38. Global Blood Transfusion Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Blood Transfusion Diagnostics Market

40. Blood Transfusion Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Blood Transfusion Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Blood Transfusion Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Blood Transfusion Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer